e-learning
resources
Vienna 2009
Monday, 14.09.2009
Various diagnostic aspects in lung cancer and rare lung tumours
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
6-minute-walk in lung cancer – a new predictor for response and the performance status?
E. Schumann, H. Golpon, S. Fischer, T. Welte, N. Dickgreber (Hannover, Germany)
Source:
Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Session:
Various diagnostic aspects in lung cancer and rare lung tumours
Session type:
Thematic Poster Session
Number:
2701
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Schumann, H. Golpon, S. Fischer, T. Welte, N. Dickgreber (Hannover, Germany). 6-minute-walk in lung cancer – a new predictor for response and the performance status?. Eur Respir J 2009; 34: Suppl. 53, 2701
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Postoperative predicting value of lung function in patients with lung cancer – Fortune-telling or reality? Evaluation after surgical treatment
Source: Annual Congress 2011 - Lung function today and tomorrow II
Year: 2011
Detection of lung cancer on CXR – A comparison of radiologist‘s performance
Source: Annual Congress 2010 - Quality management for lung cancer patients
Year: 2010
Lung function in lung cancer – Room for improvement?
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011
Postoperative complications after pneumonectomy in lung cancer patients – Whether lung function can act as a predictor?
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010
Survival outcomes in advance non-small cell lung cancer – A developing country scenario
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011
Six minute walk test (6MWT) in patients with diagnosis of lung cancer – Clinical value in physiological evaluation candidates for surgical treatment
Source: Annual Congress 2012 - Pre-operative evaluation in thoracic surgery
Year: 2012
COPD prevalence in lung cancer patients – Is COPD a risk factor for lung cancer?
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011
Exercise testing to predict lung cancer surgery outcome: which is better - percentage of predicted VO2 or absolute value?
Source: Eur Respir J 2004; 24: Suppl. 48, 672s
Year: 2004
Tuberculosis – An important risk factor for lung cancer
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010
Lung function and quality of life after surgical treatment of non-small cell lung cancer – preliminary results
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009
Is the speed & likelihood of diagnosis of lung cancer influenced by referral origin?
Source: Annual Congress 2010 - Quality management for lung cancer patients
Year: 2010
Multiple kinds of cancer in one person – Lung and breast cancer – And other malignant entities
Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series
Year: 2010
EGFR
and
hTERT
mRNA expression in non-small cell lung cancer patients – Diagnostic and prognostic implications
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Who win? Spirometry versus symptoms for predicting the longitudinal outcomes in COPD patients – 10 years observation
Source: Annual Congress 2011 - Clinical parameters in airway diseases
Year: 2011
Freeflowmetry – The new method of evaluation of the respiratory function phenotype
Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases
Year: 2011
The effect of post operative physical training on activity after curative surgery for non small cell lung cancer (NSCLC) – RCT
Source: Annual Congress 2012 - The best abstracts in pulmonary rehabilitation
Year: 2012
Completion pneumonectomy for lung cancer relapse after surgery – what is a real benefit?
Source: Annual Congress 2009 - Current challenges in thoracic surgery
Year: 2009
Rapid access lung cancer clinic – A patient satisfaction survey
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011
Assessment of German national lung cancer guideline quality indicators in routine practice – Does the new TNM-system make a difference?
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011
Breathlessness-inducing exercise in advanced cancer populations. Which measures to use as functional status declines?
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept